Federal Register-02-28529

Federal Register / Vol. 67, No.
217 / Friday, November 8, 2002 / Notices 68149
a government I.D. will need to show a Name of Committee: National Institute on Date: December 2, 2002.
photo I.D. and sign-in at the security Aging Special Emphasis Panel, Human Time: 1:30 p.m. to 3:30 p.m.
desk upon entering the building. Genetics. Agenda: To review and evaluate grant
Date: November 18–19, 2002. applications.
Information is also available on the Time: 7 p.m. to 5 p.m. Place: One Democracy Plaza, 6701
Institute’s/Center’s home page: Agenda: To review and evaluate grant Democracy Blvd., Suite 800, Bethesda, MD
deainfo.nci.nih.gov/advisory/ncab.htm, applications. 20892, (Telephone Conference Call).
where an agenda and any additional Place: The Iberville Suites—New Orleans, Contact Person: Tracy A Shahan, Ph.D.,
information for the meeting will be 910 Iberville Street, New Orleans, LA 70112. Scientific Review Administrator, National
Contact Person: Alicja L. Markowska, Institute of Arthritis and Musculoskeletal and
posted when available.
Ph.D., DSC, Scientific Review Office, Skin Diseases, 6701 Democracy Plaza,
(Catalogue of Federal Domestic Assistance Gateway Building/Suite 2C212, 7201 Bethesda, MD 20892, (301) 594–4952.
Program Nos. 93.392, Cancer Construction; Wisconsin Avenue, Bethesda, MD 20817.
(Catalogue of Federal Domestic Assistance
93.393, Cancer Cause and Prevention This notice is being published less than 15
Program Nos. 93.846, Arthritis,
Research; 93.394, Cancer Detection and days prior to the meeting due to the timing
Musculoskeletal and Skin Diseases Research,
Diagnosis Research; 93.395, Cancer limitations imposed by the review and
National Institutes of Health, HHS)
Treatment Research; 93.396, Cancer Biology funding cycle.
Dated: November 4, 2002.
Research; 93.397, Cancer Centers Support; Name of Committee: National Institute on
93.398, Cancer Research Manpower; 93.399, Aging Special Emphasis Panel, Intervention LaVerne Y. Stringfield,
Cancer Control, National Institutes of Health, Panel. Director, Office of Federal Advisory
HHS) Date: November 21, 2002. Committee Policy.
Dated: November 1, 2002. Time: 8 a.m. to 3:30 p.m. [FR Doc. 02–28528 Filed 11–7–02; 8:45 am]
Agenda: To review and evaluate grant
LaVerne Y. Stringfield, BILLING CODE 4140–01–M
applications.
Director, Office of Federal Advisory Place: Gateway Building, 7201 Wisconsin
Committee Policy. Avenue/Suite 2C212, Bethesda, MD 20814.
Contact Person: Arthur D. Schaerdel, DVM,
DEPARTMENT OF HEALTH AND
[FR Doc. 02–28534 Filed 11–7–02; 8:45 am]
The Bethesda Gateway Building, 7201 HUMAN SERVICES
BILLING CODE 4140–01–M
Wisconsin Avenue/Suite 2C212, Bethesda,
MD 20892, (301) 496–9666. National Institutes of Health
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance National Institutes on Drug Abuse;
HUMAN SERVICES Program Nos. 93.866, Aging Research, Notice of Closed Meetings
National Institutes of Health, HHS)
National Institutes of Health Dated: November 4, 2002. Pursuant to section 10(d) of the
Anna Snouffer, Federal Advisory Committee Act, as
National Institute on Aging; Notice of Deputy Director, Office of Federal Advisory amended (5 U.S.C. Appendix 2), notice
Closed Meetings Committee Policy. is hereby given of the following
[FR Doc. 02–28527 Filed 11–7–02; 8:45 am] meetings.
Pursuant to section 10(d) of the The meetings will be closed to the
BILLING CODE 4140–01–M
Federal Advisory Committee Act, as public in accordance with the
amended (5 U.S.C. Appendix 2), notice provisions set forth in sections
is hereby given of the following DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
meetings. HUMAN SERVICES as amended. The grant applications and
The meetings will be closed to the the discussions could disclose
public in accordance with the National Institutes of Health confidential trade secrets or commercial
provisions set forth in sections property such as patentable material,
552b(c)(4) and 552(c)(6), Title 5 U.S.C., National Institute of Arthritis and and personal information concerning
as amended. The grant applications and Musculoskeletal and Skin Diseases; individuals associated with the grant
the discussions could disclose Notice of Closed Meeting applications, the disclosure of which
confidential trade secrets or commercial Pursuant to section 10(d) of the would constitute a clearly unwarranted
property such as patentable material, Federal Advisory Committee Act, as invasion of personal privacy.
and personal information concerning amended (5 U.S.C. Appendix 2), notice Name of Committee: National Institute on
individuals associated with the grant is hereby given of the following Drug Abuse Special Emphasis Panel, Program
applications, the disclosure of which meeting. Project.
would constitute a clearly unwarranted The meeting will be closed to the Date: November 20, 2002.
Time: 10 am to 2 pm.
invasion of personal privacy. public in accordance with the Agenda: To review and evaluate grant
Name of Committee: National Institute on provisions set forth in sections applications.
Aging Special Emphasis Panel, T32’s. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: 6001 Executive Boulevard, Suite
Date: November 12–14, 2002. as amended. The grant applications and 3158, Bethesda, MD 20892–9547 (Telephone
Time: 7 p.m. to 5 p.m. the discussions could disclose Conference Call).
Agenda: To review and evaluate grant confidential trade secrets or commercial Contact Person: Khursheed Asghar, Ph.D.,
applications. property such as patentable material, Chief, Basic Sciences Review Branch, Office
Place: Chevy Chase Holiday Inn, 5520 and personal information concerning of Extramural Affairs, National Institute on
Wisconsin Ave., Chevy Chase, MD 20815. individuals associated with the grant Drug Abuse, National Institutes of Health,
Contact Person: Jeffrey M. Chernak, Ph.D., DHHS, 6001 Executive Boulevard, Room
applications, the disclosure of which 3158, MSC 9547, Bethesda, MD 20892–9547,
The Bethesda Gateway Building, 7201
would constitute a clearly unwarranted (301) 443–2620.
Wisconsin Avenue/Suite 2C212, Bethesda,
MD 20892, (301) 496–9666. invasion of personal privacy. Name of Committee: National Institute on
This notice is being published less than 15 Name of Committee: National Institute of Drug Abuse Special Emphasis Panel,
days prior to the meeting due to the timing Arthritis and Musculoskeletal and Skin Minority Institutions’ Drug Abuse Research
limitations imposed by the review and Diseases Special Emphasis Panel, Gordon Development Program (MIDARP).
funding cycle. Conference Review. Date: December 5, 2002.
VerDate 0ct<31>2002 17:16 Nov 07, 2002 Jkt 200001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1
68150 Federal Register / Vol. 67, No. 217 / Friday, November 8, 2002 / Notices
Time: 9 am to 5 pm. Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Arthritis and Skin Diseases Special Program Nos. 93.846, Arthritis,
applications. Emphasis, Panel. R03’s Small Grants for New Musculoskeletal and Skin Diseases Research,
Place: Radisson Barcelo, 2121 P Street, Investigators. National Institutes of Health, HHS)
NW., Washington, DC 20037. Date: December 16, 2002. Dated: November 4, 2002.
Contact Person: Marina L. Volkov, Ph.D., Time: 8:30 a.m. to 5 p.m. LaVerne Y. Springfield,
Health Scientist Administrator, Office of Agenda: To review and evaluate grant
Extramural Affairs, National Institute on applications. Director, Office of Federal Advisory
Drug Abuse, National Institutes of Health, Place: Double Tree Hotel, 1750 Rockville Committee Policy.
DHHS, 6001 Executive Boulevard, Room Pike, Rockville, MD 20852. [FR Doc. 02–28531 Filed 11–07–02; 8:45 am]
3158, MSC 9547, Bethesda, MD 20892–9547, Contract Person: Richard J. Bartlett, Ph.D., BILLING CODE 4140–01–M
(301) 435–1433. Scientific Review Administrator, National
Name of Committee: National Institute on Institute of Arthritis and Musculoskeletal and
Drug Abuse Special Emphasis Panel, Program Skin Diseases, 6701 Democracy Plaza, DEPARTMENT OF HEALTH AND
Project. Bethesda, MD 20892, (301) 594–4952. HUMAN SERVICES
Date: December 16, 2002. (Catalogue of Federal Domestic Assistance
Time: 10 am to 2 pm. Program Nos. 93.846, Arthritis, National Institute of Dental &
Agenda: To review and evaluate grant Musculoskeletal and Skin Diseases Research, Craniofacial Research; Notice of
applications. National Institutes of Health, HHS) Closed Meetings
Place: Fairmont Hotel, 2401 M Street, NW., Dated: November 4, 2002.
Washington, DC 20037. Pursuant to section 10(d) of the
Contact Person: Khursheed Asghar, Ph.D., LaVerne Y. Stringfield, Federal Advisory Committee Act, as
Chief, Basic Sciences Review Branch, Office Director, Office of Federal Advisory amended (5 U.S.C. Appendix 2), notice
of Extramural Affairs, National Institute on Committee Policy. is hereby given of the following
Drug Abuse, National Institutes of Health, [FR Doc. 02–28530 Filed 11–7–02; 8:45 am] meetings.
DHHS, 6001 Executive Boulevard, Room BILLING CODE 4140–01–M The meetings will be closed to the
3158, MSC 9547, Bethesda, MD 20892–9547,
public in accordance with the
(301) 443–2620.
provisions set forth in sections
DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
(Catalogue of Federal Domestic Assistance
HUMAN SERVICES as amended. The grant applications and
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist the discussions could disclose
National Institutes of Health confidential trade secrets or commercial
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
National Institute of Arthritis and property such as patentable material,
Research Service Awards for Research and personal information concerning
Training; 93.279, Drug Abuse Research Musculoskeletal and Skin Diseases;
Notice of Closed Meeting individuals associated with the grant
Programs, National Institutes of Health, HHS) applications, the disclosure of which
Dated: November 4, 2002. would constitute a clearly unwarranted
Pursuant to section 10(d) of the
LaVerne Y. Stringfield, invasion of personal privacy.
Federal Advisory Committee Act, as
Director, Office of Federal Advisory amended (5 U.S.C. Appendix 2), notice Name of Committee: National Institute of
Committee Policy. Dental and Craniofacial Research Special
is hereby given of the following
[FR Doc. 02–28529 Filed 11–7–02; 8:45 am] meeting. Emphasis Panel, 03–27 Review of R21
BILLING CODE 4140–01–M Grants.
The meeting will be closed to the Date: December 12, 2002.
public in accordance with the Time: 3 p.m. to 5 p.m.
DEPARTMENT OF HEALTH AND provisions set forth in sections Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C. applications.
HUMAN SERVICES Place: 45 Center Drive, Bethesda, MD
as amended. The grant applications and
the discussions could disclose 20892, (Telephone Conference Call).
National Institutes of Health Contact Person: H. George Hausch, Ph.D.,
confidential trade secrets or commercial Acting Director, 4500 Center Drive, Natcher
National Institute of Arthritis and property such as patentable material, Building, Rm. 4AN44F, National Institute of
Musculoskeletal and Skin Diseases; and personal information concerning Health, Bethesda, MD 20892, (301) 594–2372.
Notice of Closed Meeting individuals associated with the grant Name of Committee: National Institute of
applications, the disclosure of which Dental and Craniofacial Research Special
Pursuant to section 10(d) of the would constitute a clearly unwarranted Emphasis Panel, 03–14 Review of R44
Federal Advisory Committee Act, as invasion of personal privacy. Grants.
amended (5 U.S.C. Appendix 2), notice Date: December 19, 2002.
is hereby given of the following Name of Committee: National Institute of Time: 1 p.m. to 3 p.m.
Arthritis and Musculoskeletal and Skin Agenda: To review and evaluate grant
meeting.
Diseases Special Emphasis Panel, Bone applications.
The meeting will be closed to the Marrow. Place: 45 Center Drive, Bethesda, MD
public in accordance with the Date: December 2, 2002. 20892, (Telephone Conference Call).
provisions set forth in sections Time: 12 p.m. to 1 p.m. Time: 1 p.m. to 3 p.m.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant Agenda: To review and evaluate grant
as amended. The grant applications and applications. applications.
the discussions could disclose Place: 1 Democracy, 6701 Democracy Place: 45 Center Drive, Bethesda, MD
confidential trade secrets or commercial Blvd., Suite 707 MSC 4879, (Telephone 20892, (Telephone Conference Call).
Conference Call). Contact Person: Philip Washko, Ph.D.,
property such as patentable material, DMD, Scientific Review Administrator, 45
Contact Person: Tracy A. Shahan, Ph.D.,
and personal information concerning Scientific Review Administrator, National Center Drive, Natcher Building, Rm. 4AN44F,
individuals associated with the grant Institute of Arthritis and Musculoskeletal and National Institute of Health, Bethesda, MD
applications, the disclosure of which Skin Diseases, Natcher Building, MSC 6500, 20892, (301) 594–2372.
would constitute a clearly unwarranted 45 Center Drive, 5AS–25H, Bethesda, MD Name of Committee: National Institute of
invasion of personal privacy. 20892, (301) 594–4952. Dental and Craniofacial Research Special
VerDate 0ct<31>2002 16:24 Nov 07, 2002 Jkt 200001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1

Federal Register-02-28529

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Federal Register-02-28529

Uploaded by

Copyright:

Available Formats

Federal Register / Vol. 67, No.

217 / Friday, November 8, 2002 / Notices 68149

You might also like